GL1X · GenesisL1 explorer

Ligand · DRI

DRI · 2,6-dideoxy-4-O-methyl-beta-D-glucopyranose

DRI, 2,6-dideoxy-4-O-methyl-beta-D-glucopyranose (C7 H14 O4, 162.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…

Component
DRI
Formula
C7 H14 O4
Class
sugar
Structures
2
PDB entries
1

Binding sites

DRI in 2 structures; the first of them:

  • 1CP8 · NMR structure of DNA (5'-D(TTGGCCAA)2-3') complexed with novel antitumor drug UCH9 · DRI C3 · binds DA7, DA8
  • 1CP8 · NMR structure of DNA (5'-D(TTGGCCAA)2-3') complexed with novel antitumor drug UCH9 · DRI C3 · binds DA7, DA8

Residues it binds most

DA 4 (residue and the binding sites it lines).

Found with

  • DDA · beta-D-Olivopyranose
  • DXA · 1,2-hydro-1-oxy-3,4-hydro-3-(1-methoxy-2-oxy-3,4-dihydroxypentyl)-8,9-dihydroxy-7-(sec-butyl)-anthracene
  • MG · Magnesium ion
  • DDL · 2,6-dideoxy-beta-D-galactopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.